Back to Search Start Over

Prevalence of atherogenic dyslipidemia, related factors and level of lipid control in the general population of Galicia. GALIPEMIAS study.

Authors :
Názara C
Argüeso RM
Pedro-Botet J
Pintó X
Millán J
Pena Seijo M
Fernández PA
Eugenia Ameneiros M
Del Alamo A
Rodríguez A
Díaz-Peromingo JA
Vázquez Freire MR
Muñiz J
Pérez-Castro TR
Díaz-Díaz JL
Pose Reino A
Source :
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis [Clin Investig Arterioscler] 2023 Jul-Aug; Vol. 35 (4), pp. 178-184. Date of Electronic Publication: 2023 Jan 28.
Publication Year :
2023

Abstract

Objectives: GALIPEMIAS is a study designed to establish the prevalence of familial dyslipidemia in the general population of Galicia. The objective of the present study was to assess the prevalence of atherogenic dyslipidemia (AD), its relationship with other cardiovascular risk (CVR) factors, and the degree of lipid control.<br />Methods: Cross-sectional study carried out in the general population over 18 years of age residing in Galicia and with a health card from the Galician Health Service (N=1,000). Selection of the sample by means of random sampling by conglomerates. The AD prevalence adjusted for age and sex and the related variables were analyzed.<br />Results: The prevalence of AD adjusted for age and sex was 6.6% (95% CI: 5.0-8.3%). Arterial hypertension, altered basal glycemia, type 2 diabetes mellitus and cardiovascular disease were more frequent in subjects with AD than in the rest of the population. 47.5% of the subjects with AD had a high or very high CVR. Lipid-lowering drugs were received by 38.9% (30.5% statins) of the participants with AD (46.1% of those with high and 71.4% of those with very high CVR). 25.4% of the subjects with AD had target LDL-c levels, all of them with low or moderate CVR.<br />Conclusions: The prevalence of AD in the general adult population of Galicia is not negligible, and it was related to several CVR factors and cardiovascular disease. Despite this, this lipid alteration was underdiagnosed and undertreated.<br /> (Copyright © 2022. Publicado por Elsevier España, S.L.U.)

Details

Language :
English; Spanish; Castilian
ISSN :
1578-1879
Volume :
35
Issue :
4
Database :
MEDLINE
Journal :
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Publication Type :
Academic Journal
Accession number :
36717323
Full Text :
https://doi.org/10.1016/j.arteri.2022.11.002